Literature DB >> 20961910

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.

A Calcagno, L Baietto, F G De Rosa, M C Tettoni, V Libanore, R Bertucci, A D'Avolio, G Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20961910     DOI： 10.1093/jac/dkq385

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

2.  Reflections on the approach to treatment of a mycologic disaster.

Authors:  David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

Review 3.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).

Authors:  Anjan Debnath; Claudia M Calvet; Gareth Jennings; Wenxu Zhou; Alexander Aksenov; Madeline R Luth; Ruben Abagyan; W David Nes; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2017-12-28

Review 5.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08

Review 6.  Central Nervous System Infection with Histoplasma capsulatum.

Authors:  James Riddell; L Joseph Wheat
Journal:  J Fungi (Basel)       Date:  2019-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.